On Tuesday, the European Commission presented a draft for Council conclusions on smoke- and aerosol-free environments. The goal is for the Council of Ministers to adopt the recommendations in the coming months and for the member states to then implement them. The aim is to ban smoking in all public buildings, as well as in certain outdoor areas, e.g., at children's playgrounds.
Dr. Peter Liese, the health policy spokesperson for the largest group in the European Parliament (EPP-Christian Democrats) and a physician, stated: “It is important that we adopt measures at all levels to protect people from tobacco smoke. Smoking is particularly dangerous for the smokers themselves. There is nothing better one can do for their health than to quit smoking. Other health protection measures such as exercise and healthy eating are also important, but stopping smoking brings the most significant benefits by far. Protecting other people, especially children, from tobacco is also extremely sensible.”
Read more: The Commission presents a draft for Council recommendations on smoke-free environments
"The EU member states should provide a coordinated response to the outbreak of the new Clade Ib variant of the Mpox virus in Africa and other parts of the world," stated the health policy spokesperson for the largest group in the European Parliament (EPP-Christian Democrats), Dr. Peter Liese, ahead of a discussion by the Committee on the Environment, Public Health, and Food Safety in the European Parliament on Wednesday.
Prompted by the EPP Group, the European Commission, the Health Emergency Preparedness and Response Authority (HERA) responsible for vaccine procurement, the European Medicines Agency (EMA), and the European Centre for Disease Prevention and Control (ECDC) will address questions from the Members of Parliament. The meeting is set for Wednesday morning at about 09:30. "Although two Europeans1 have now been affected, we must remain composed and not overreact. There is no indication that Mpox will affect nearly as many people in Europe or cause as many deaths as COVID-19. The hygienic conditions in Europe are much better than in the affected region of Africa, so the risk of infection is much lower. Furthermore, medical care seems to play an extremely significant role in determining whether an affected patient survives. In a clinical trial for a relevant medication, it was found, that survival rates drastically increased with treatment. However, even those who received a placebo survived much more frequently, simply because they received proper medical care by being included in the clinical trial2," Liese said.
Read more: European Parliament's Committee on Environment and Health discusses Mpox Outbreak
Dr. Peter Liese, environmental policy spokesperson for the largest political group in the European Parliament (EPP, Christian Democrats), welcomed the selection of Commissioners by Commission President Ursula von der Leyen for the climate and environment dossiers. Wopke Hoesktra will remain Climate Commissioner. “In contrast to his predecessor Frans Timmermans, Wopke Hoekstra has been very active in international climate policy and was involved in a major breakthrough at the climate conference in Dubai just a few weeks after his appointment. We cannot stop climate change on our own, but must focus much more on global emissions. Wopke Hoekstra is the right man for the job. Jessika Roswall, the current Swedish Minister for Europe, is to become Commissioner for the Environment. I think this is a good choice. We need a more pragmatic approach to environmental policy, above all less bureaucracy, and in the event of conflicting objectives, e.g. between bans on chemicals and climate protection, decisions must be taken in favour of climate protection.”
“The European Union is well prepared for the outbreak of the new variant of Mpox (formerly ‘monkeypox’) clade I type 2,” said Dr Peter Liese, health spokesperson for the largest political group in the European Parliament (EPP, Christian Democrats), in view of the second official case of Mpox outside Africa. On Thursday evening, it became known that a European who had travelled from Africa to Thailand had been infected with the new variant of Mpox. “Due to the intensive travel activity between the affected African countries and Europe, I expect that there will be at least individual cases in all European countries. Nevertheless, we should all remain calm. Vaccines are already available and the risk groups can be vaccinated at short notice. The European institutions, in particular the Commission's newly created unit ‘HERA’ (European Health Emergency Response Authority), have concluded a contract with the German-Danish vaccine manufacturer Bavarian Nordic for the supply of 2 million vaccine doses in 2022. In addition, vaccine doses worth around 86 million euros are available via the RescEU mechanism. These are supplemented by contracts concluded by the individual member states. In addition to securing vaccine, the European Union has also strengthened the structures in the European ‘health authority’ ECDC and the European Medicines Agency EMA after Corona,” emphasised Liese.